• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实验室标志物组合DOVER和QUVER用于检测医生诊断的高危饮酒的有效性。

The validity of the laboratory marker combinations DOVER and QUVER to detect physician's diagnosis of at-risk drinking.

作者信息

Bentele Michael, Kriston Levente, Clement Hans-Willi, Härter Martin, Mundle Götz, Berner Michael M

机构信息

Freiburg University Hospital, Department of Psychiatry and Psychotherapy, Freiburg, Germany.

出版信息

Addict Biol. 2007 Mar;12(1):85-92. doi: 10.1111/j.1369-1600.2006.00049.x.

DOI:10.1111/j.1369-1600.2006.00049.x
PMID:17407501
Abstract

Especially in situations where it might be favorable for the patient to dissimulate the existing alcohol problem, 'objective' laboratory tests can be helpful. In this study we report validation of the two combinations DOVER (DOctor VERified) and QUVER (QUestionnarie VERified) of the biological markers percent carbohydrate-deficient transferrin (%CDT) and gamma-glutamyl-transferase (gamma-GT) to detect patients that have been identified by their physicians with at-risk drinking behavior. Fifty-eight general practitioners (GPs) participated at two study sites in South-West Germany. Patients filled in a questionnaire that included the alcohol use disorders identification test (AUDIT) and gave a blood sample. The GP recorded his/her assessment about the presence of an alcohol-related disorder in the patient. Receiver operating characteristics (ROC) analyses of the marker combinations DOVER and QUVER were performed. A total of 2940 patients participated in the study, of which 2496 completed data sets that could be used for further analysis. The area under the curve (AUC) of 79.5% for DOVER and 77.2% (QUVER) are in a higher range than the values for gamma%CDT (75.7%) or gamma-GT (72.5%) and %CDT (64.5%) and suggest superiority of the proposed marker combinations. Cross-validation results were almost identical with 76.6% and 73.3% for DOVER and QUVER, respectively. Our analysis demonstrated that the combination of the markers gamma-GT and %CDT with the physician's judgement of the condition as reference was superior to the use of single markers.

摘要

特别是在患者可能倾向于隐瞒现有酒精问题的情况下,“客观”的实验室检测会有所帮助。在本研究中,我们报告了生物标志物碳水化合物缺乏转铁蛋白百分比(%CDT)和γ-谷氨酰转移酶(γ-GT)的两种组合DOVER(医生验证)和QUVER(问卷验证)用于检测经医生认定有危险饮酒行为患者的验证情况。58名全科医生(GP)参与了德国西南部两个研究地点的研究。患者填写了一份包含酒精使用障碍识别测试(AUDIT)的问卷并提供了血样。全科医生记录了其对患者是否存在酒精相关障碍的评估。对DOVER和QUVER标志物组合进行了受试者操作特征(ROC)分析。共有2940名患者参与了该研究,其中2496名患者完成了可用于进一步分析的数据集。DOVER的曲线下面积(AUC)为79.5%,QUVER为77.2%,高于γ%CDT(75.7%)、γ-GT(72.5%)和%CDT(64.5%)的值,表明所提出的标志物组合具有优越性。交叉验证结果几乎相同,DOVER和QUVER分别为76.6%和73.3%。我们的分析表明,以医生对病情的判断为参考,γ-GT和%CDT标志物的组合优于单一标志物的使用。

相似文献

1
The validity of the laboratory marker combinations DOVER and QUVER to detect physician's diagnosis of at-risk drinking.实验室标志物组合DOVER和QUVER用于检测医生诊断的高危饮酒的有效性。
Addict Biol. 2007 Mar;12(1):85-92. doi: 10.1111/j.1369-1600.2006.00049.x.
2
DOVER and QUVER-new marker combinations to detect and monitor at-risk drinking.多佛和奎弗——用于检测和监测危险饮酒的新型标志物组合
Alcohol Clin Exp Res. 2006 Aug;30(8):1372-80. doi: 10.1111/j.1530-0277.2006.00163.x.
3
Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin.碳水化合物缺乏转铁蛋白(%CDT)、γ-谷氨酰转移酶(γ-GT)和平均红细胞体积(MCV)作为慢性酒精滥用生物标志物的有效性:一项针对酒精依赖患者以及非酒精性和酒精性肝病患者的研究
Addiction. 2005 Oct;100(10):1477-86. doi: 10.1111/j.1360-0443.2005.01216.x.
4
Screening properties of questionnaires and laboratory tests for the detection of alcohol abuse or dependence in a general practice population.在普通门诊人群中检测酒精滥用或依赖的问卷及实验室检查的筛查特性。
Br J Gen Pract. 2001 Mar;51(464):206-17.
5
Comparison of new alcohol use test, the Helsinki Alcohol Use Test questionnaire, and Alcohol Use Disorders Identification Test and laboratory markers serum gamma-glutamyl transferase and carbohydrate-deficient transferrin.新型酒精使用测试、赫尔辛基酒精使用测试问卷、酒精使用障碍识别测试以及实验室指标血清γ-谷氨酰转移酶和缺糖转铁蛋白的比较。
Addict Behav. 2004 Jun;29(4):717-22. doi: 10.1016/j.addbeh.2004.02.001.
6
Detection of alcohol abuse in neurological patients: variables of clinical relevance to the accuracy of the %CDT-TIA and CDTect methods.神经科患者酒精滥用的检测:与%CDT-TIA和CDTect方法准确性相关的临床变量。
Alcohol Clin Exp Res. 2001 Jan;25(1):46-53.
7
Enhanced clinical utility of gamma-CDT in a general population.γ-谷氨酰转肽酶在普通人群中的临床应用价值增强。
Alcohol Clin Exp Res. 2000 Aug;24(8):1202-6.
8
Sex differences of carbohydrate-deficient transferrin, gamma-glutamyltransferase, and mean corpuscular volume in alcohol-dependent patients.酒精依赖患者中缺糖转铁蛋白、γ-谷氨酰转移酶和平均红细胞体积的性别差异。
Alcohol Clin Exp Res. 2000 Sep;24(9):1400-5.
9
Phosphatidylethanol as a sensitive and specific biomarker: comparison with gamma-glutamyl transpeptidase, mean corpuscular volume and carbohydrate-deficient transferrin.磷脂酰乙醇作为一种敏感且特异的生物标志物:与γ-谷氨酰转肽酶、平均红细胞体积及缺糖转铁蛋白的比较
Addict Biol. 2007 Mar;12(1):81-4. doi: 10.1111/j.1369-1600.2006.00040.x.
10
[The diagnostic validity of screening tests and laboratory markers in alcohol use disorders].[酒精使用障碍筛查试验和实验室标志物的诊断效度]
Turk Psikiyatri Derg. 2005 Spring;16(1):3-12.

引用本文的文献

1
Alcohol withdrawal syndrome: mechanisms, manifestations, and management.酒精戒断综合征:机制、表现及管理
Acta Neurol Scand. 2017 Jan;135(1):4-16. doi: 10.1111/ane.12671. Epub 2016 Sep 1.